标题
Current applications of multiparameter flow cytometry in plasma cell disorders
作者
关键词
-
出版物
Blood Cancer Journal
Volume 7, Issue 10, Pages e617
出版商
Springer Nature
发表日期
2017-10-20
DOI
10.1038/bcj.2017.90
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
- (2017) Miquel Granell et al. HAEMATOLOGICA
- Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
- (2017) Juan-Jose Lahuerta et al. JOURNAL OF CLINICAL ONCOLOGY
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
- (2017) J Flores-Montero et al. LEUKEMIA
- Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
- (2017) J Martinez-Lopez et al. LEUKEMIA
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
- (2017) Yuji Mishima et al. Cell Reports
- Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
- (2017) Miquel Granell et al. HAEMATOLOGICA
- Origin of Waldenstrom's macroglobulinaemia
- (2016) Ramón García-Sanz et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis
- (2016) B. Paiva et al. BLOOD
- Minimal residual disease is an independent predictor for 10-year survival in CLL
- (2016) M. Kwok et al. BLOOD
- The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
- (2016) Eli Muchtar et al. BLOOD
- Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
- (2016) Prisca Theunissen et al. BLOOD
- Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
- (2016) B. Paiva et al. BLOOD
- Monoclonal antibodies — A new era in the treatment of multiple myeloma
- (2016) Tomas Jelinek et al. BLOOD REVIEWS
- Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
- (2016) Jorge J. Castillo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Abstract 3123: Aberrant expression of CD33 is associated with poor prognosis in patients with multiple myeloma and tumor progression
- (2016) Ki Hong Lee et al. CANCER RESEARCH
- Immunomodulatory drugs in AL amyloidosis
- (2016) T. Jelinek et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Utility of flow cytometry studies in the management of patients with multiple myeloma
- (2016) Bruno Paiva et al. CURRENT OPINION IN ONCOLOGY
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
- (2016) W I Gonsalves et al. LEUKEMIA
- Differentiation stage of myeloma plasma cells: biological and clinical significance
- (2016) B Paiva et al. LEUKEMIA
- Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete response
- (2016) Kota Fukumoto et al. LEUKEMIA & LYMPHOMA
- The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma
- (2016) Wilson I. Gonsalves et al. LEUKEMIA RESEARCH
- Plasma Cell Disorders
- (2016) Jorge J. Castillo PRIMARY CARE
- Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
- (2016) J. G. Lohr et al. Science Translational Medicine
- Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis
- (2016) Katharina Lisenko et al. Cancer Medicine
- PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
- (2016) T. Jelinek et al. OncoImmunology
- Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF
- (2015) J. E. Huffman et al. BLOOD
- The cellular origin and malignant transformation of Waldenstrom macroglobulinemia
- (2015) B. Paiva et al. BLOOD
- Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics
- (2015) Davide Vagnoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases
- (2015) Fanny Pojero et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents
- (2015) Vittorio Emanuele Muccio et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
- (2015) Maria Arroz et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition
- (2015) Maryalice Stetler-Stevenson et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
- (2015) Juan Flores-Montero et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients
- (2014) Eirini Katodritou et al. AMERICAN JOURNAL OF HEMATOLOGY
- Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients
- (2014) Gang An et al. ANNALS OF HEMATOLOGY
- Solitary bone plasmacytomas need to flow
- (2014) M. A. Dimopoulos et al. BLOOD
- CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma
- (2014) M. E. Murray et al. BLOOD
- Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma
- (2014) B. Paiva et al. BLOOD
- Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis
- (2014) Q. A. Hill et al. BLOOD
- Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?
- (2014) D. Grimwade et al. BLOOD
- Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
- (2014) J. Martinez-Lopez et al. BLOOD
- Curing myeloma at last: defining criteria and providing the evidence
- (2014) B. Barlogie et al. BLOOD
- The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
- (2014) B. Paiva et al. HAEMATOLOGICA
- Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome
- (2014) Murielle Roussel et al. JOURNAL OF CLINICAL ONCOLOGY
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
- (2014) W I Gonsalves et al. LEUKEMIA
- Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
- (2013) B. Paiva et al. BLOOD
- Improved accuracy of discrimination between IgM Multiple Myeloma and Waldenström Macroglobulinaemia by testing forMYD88L265P mutations
- (2013) Wolfgang Willenbacher et al. BRITISH JOURNAL OF HAEMATOLOGY
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
- (2013) N Puig et al. LEUKEMIA
- A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control
- (2013) B Paiva et al. LEUKEMIA
- Multiparameter flow cytometry for the identification of the Waldenström’s clone in IgM-MGUS and Waldenström’s Macroglobulinemia: new criteria for differential diagnosis and risk stratification
- (2013) B Paiva et al. LEUKEMIA
- CD200 expression in patients with Multiple Myeloma: Another piece of the puzzle
- (2013) Concetta Conticello et al. LEUKEMIA RESEARCH
- Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients with Myeloma Included in the Spanish GEM2000 and GEM2005
- (2012) Bruno Paiva et al. AMERICAN JOURNAL OF PATHOLOGY
- Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia
- (2012) R García-Sanz et al. Clinical Lymphoma Myeloma & Leukemia
- Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
- (2012) B Paiva et al. LEUKEMIA
- High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
- (2012) G Bianchi et al. LEUKEMIA
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- MYD88 L265P Somatic Mutation in IgM MGUS
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis
- (2011) B. Paiva et al. BLOOD
- High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
- (2011) B. Paiva et al. BLOOD
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
- (2011) S. V. Rajkumar et al. BLOOD
- Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
- (2011) F. Gay et al. BLOOD
- CD200 expression in plasma cell myeloma
- (2011) Horatiu Olteanu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Circulating plasma cells predict the outcome of relapsed or refractory multiple myeloma
- (2011) Valdas Peceliunas et al. LEUKEMIA & LYMPHOMA
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
- (2010) M. Sant et al. BLOOD
- CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features
- (2010) M. Schmidt-Hieber et al. HAEMATOLOGICA
- Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells
- (2010) A. Caraux et al. HAEMATOLOGICA
- The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients
- (2009) B. Paiva et al. BLOOD
- Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
- (2009) Ernesto Pérez-Persona et al. BRITISH JOURNAL OF HAEMATOLOGY
- Constitutively lower expressions of CD54 on primary myeloma cells and their different localizations in bone marrow
- (2009) Mohd S. Iqbal et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
- (2008) Gema Mateo et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now